Survival rates of familial and sporadic prostate cancer patients
Aim: To compare cancer-specific survival rates for familial and sporadic prostate cancer patients. Materials and Methods: Gleason score and age at diagnosis of familial group and sporadic group were compared by χ² and t-test. Cancer-specific survival rates were analyzed by the Kaplan — Meier method...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2015 |
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2015
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/145473 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Survival rates of familial and sporadic prostate cancer patients / J. Plonis, M. Nakazawa-Miklasevica, A. Malevskis, P. Vaganovs, S. Pildava, E. Vjaters, J. Gardovskis, E. Miklasevics // Experimental Oncology. — 2015. — Т. 37, № 2. — С. 154-155. — Бібліогр.: 12 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of Ukraine| id |
nasplib_isofts_kiev_ua-123456789-145473 |
|---|---|
| record_format |
dspace |
| spelling |
Plonis, J. Nakazawa-Miklasevica, M. Malevskis, A. Vaganovs, P. Pildava, S. Vjaters, E. Gardovskis, J. Miklasevics, E. 2019-01-22T11:44:59Z 2019-01-22T11:44:59Z 2015 Survival rates of familial and sporadic prostate cancer patients / J. Plonis, M. Nakazawa-Miklasevica, A. Malevskis, P. Vaganovs, S. Pildava, E. Vjaters, J. Gardovskis, E. Miklasevics // Experimental Oncology. — 2015. — Т. 37, № 2. — С. 154-155. — Бібліогр.: 12 назв. — англ. 1812-9269 https://nasplib.isofts.kiev.ua/handle/123456789/145473 Aim: To compare cancer-specific survival rates for familial and sporadic prostate cancer patients. Materials and Methods: Gleason score and age at diagnosis of familial group and sporadic group were compared by χ² and t-test. Cancer-specific survival rates were analyzed by the Kaplan — Meier method and compared by log-rank test. Statistically significant level was set at p < 0.05. Results: Among 1175 prostate cancer patients, familial group consisted of 215 (18.3%) patients, the sporadic group consisted of 960 (81.7%) patients. The familial group patient’s mean age at diagnosis (58.9 years old, 95% confidence interval (CI) 57.8–60.1) was significantly younger than that of sporadic group patients (67.2 years old, 95% CI 66.7–67.6) (p < 0.0001). Comparing Gleason score between familial group and sporadic group revealed no statistically significant difference. The analysis showed that 92% (95% CI 0.88–0.97) of familial group patients had a 10-year cancer-specific survival rates, which was a significantly better outcome than that of sporadic group with 69% (95% CI 0.60–0.78) 10-year cancer-specific survival rates (p = 0.0237). Conclusion: The study data demonstrate statistically significant difference between familial group and sporadic group concerning age and cancer-specific survival rates, but not Gleason score. Key Words: prostate cancer, hereditary, familial, survival rates. en Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України Experimental Oncology Short communications Survival rates of familial and sporadic prostate cancer patients Article published earlier |
| institution |
Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| collection |
DSpace DC |
| title |
Survival rates of familial and sporadic prostate cancer patients |
| spellingShingle |
Survival rates of familial and sporadic prostate cancer patients Plonis, J. Nakazawa-Miklasevica, M. Malevskis, A. Vaganovs, P. Pildava, S. Vjaters, E. Gardovskis, J. Miklasevics, E. Short communications |
| title_short |
Survival rates of familial and sporadic prostate cancer patients |
| title_full |
Survival rates of familial and sporadic prostate cancer patients |
| title_fullStr |
Survival rates of familial and sporadic prostate cancer patients |
| title_full_unstemmed |
Survival rates of familial and sporadic prostate cancer patients |
| title_sort |
survival rates of familial and sporadic prostate cancer patients |
| author |
Plonis, J. Nakazawa-Miklasevica, M. Malevskis, A. Vaganovs, P. Pildava, S. Vjaters, E. Gardovskis, J. Miklasevics, E. |
| author_facet |
Plonis, J. Nakazawa-Miklasevica, M. Malevskis, A. Vaganovs, P. Pildava, S. Vjaters, E. Gardovskis, J. Miklasevics, E. |
| topic |
Short communications |
| topic_facet |
Short communications |
| publishDate |
2015 |
| language |
English |
| container_title |
Experimental Oncology |
| publisher |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
| format |
Article |
| description |
Aim: To compare cancer-specific survival rates for familial and sporadic prostate cancer patients. Materials and Methods: Gleason score and age at diagnosis of familial group and sporadic group were compared by χ² and t-test. Cancer-specific survival rates were analyzed by the Kaplan — Meier method and compared by log-rank test. Statistically significant level was set at p < 0.05. Results: Among 1175 prostate cancer patients, familial group consisted of 215 (18.3%) patients, the sporadic group consisted of 960 (81.7%) patients. The familial group patient’s mean age at diagnosis (58.9 years old, 95% confidence interval (CI) 57.8–60.1) was significantly younger than that of sporadic group patients (67.2 years old, 95% CI 66.7–67.6) (p < 0.0001). Comparing Gleason score between familial group and sporadic group revealed no statistically significant difference. The analysis showed that 92% (95% CI 0.88–0.97) of familial group patients had a 10-year cancer-specific survival rates, which was a significantly better outcome than that of sporadic group with 69% (95% CI 0.60–0.78) 10-year cancer-specific survival rates (p = 0.0237). Conclusion: The study data demonstrate statistically significant difference between familial group and sporadic group concerning age and cancer-specific survival rates, but not Gleason score. Key Words: prostate cancer, hereditary, familial, survival rates.
|
| issn |
1812-9269 |
| url |
https://nasplib.isofts.kiev.ua/handle/123456789/145473 |
| citation_txt |
Survival rates of familial and sporadic prostate cancer patients / J. Plonis, M. Nakazawa-Miklasevica, A. Malevskis, P. Vaganovs, S. Pildava, E. Vjaters, J. Gardovskis, E. Miklasevics // Experimental Oncology. — 2015. — Т. 37, № 2. — С. 154-155. — Бібліогр.: 12 назв. — англ. |
| work_keys_str_mv |
AT plonisj survivalratesoffamilialandsporadicprostatecancerpatients AT nakazawamiklasevicam survivalratesoffamilialandsporadicprostatecancerpatients AT malevskisa survivalratesoffamilialandsporadicprostatecancerpatients AT vaganovsp survivalratesoffamilialandsporadicprostatecancerpatients AT pildavas survivalratesoffamilialandsporadicprostatecancerpatients AT vjaterse survivalratesoffamilialandsporadicprostatecancerpatients AT gardovskisj survivalratesoffamilialandsporadicprostatecancerpatients AT miklasevicse survivalratesoffamilialandsporadicprostatecancerpatients |
| first_indexed |
2025-12-07T16:09:55Z |
| last_indexed |
2025-12-07T16:09:55Z |
| _version_ |
1850866448870670336 |